Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria.

Inclusion Criteria: * male or female infants and children ≤12 years of age * body weight of ≥5 kg and \<35 kg, * with a confirmed diagnosis of uncomplicated malaria caused by the P. falciparum parasite Exclusion Criteria: * complicated malaria * persistent vomiting * malaria due to parasites other than P. falciparum * antimalarial treatment received in the past 2 weeks * known chronic disease e.g. positive HIV status, severe cardiac, renal, or hepatic disease